Evidence map›Paper›PMID 37548300›Full record

ArticleInternal medicine journal2023

Proton pump inhibitors and the risk of acquiring a penicillin allergy label.

Sarah Al-Obaydi, Catherine A Popadiuk, Taha Al-Shaikhly

Open access · hybridAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Internal medicine journal, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 87% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Sarah Al-ObaydiDepartment of Medicine, Penn State College of Medicine, Pennsylvania State University, Hershey, Pennsylvania, USA.
Catherine A PopadiukDivision of Pulmonary, Allergy & Critical Care, Department of Medicine, Penn State College of Medicine, Pennsylvania State University, Hershey, Pennsylvania, USA.
Taha Al-ShaikhlyDivision of Pulmonary, Allergy & Critical Care, Department of Medicine, Penn State College of Medicine, Pennsylvania State University, Hershey, Pennsylvania, USA.ORCID 0000-0002-1251-8937
Penn State Milton S. Hershey Medical Center · USPennsylvania State University · US

Funding

Penn State Clinical and Translational Science InstituteUL1TR002014 · NCATS · PENNSYLVANIA STATE UNIV HERSHEY MED CTR · PI KRASCHNEWSKI, JENNIFER L. · 2016 to 2025
$33.7M
NCATS NIH HHS UL1 TR002014NIH HHS UL1 TR002014
6 · The paper itself

Abstract

The negative consequences of having a penicillin allergy label are well established. Penicillin allergy de-labelling improves healthcare outcomes; however, less attention is paid to modifying risk factors leading to penicillin allergy development. In this propensity score-matched retrospective cohort study, we used a de-identified population-based database (TriNetX Research Network) and examined the 30-day risk of acquiring a penicillin allergy label in patients using proton pump inhibitors (PPIs). We demonstrated a higher risk of acquiring a penicillin allergy label among PPI users compared to controls.

Indexed as

Drug HypersensitivityHypersensitivityHumansPenicillinsProton Pump InhibitorsRetrospective StudiesRisk FactorsPenicillinsProton Pump Inhibitorsdrug allergygastric acid suppressionpenicillin allergy labelPPIproton pump inhibitors

Identifiers

PMID37548300
PMCPMC10529584
OpenAlexW4385620988

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.